Search & Analyze
Popular Searches
Concord Biotech Ltd.
Healthcare₹1,250.900.10%
24 Jul, 4:01 PM
CMP₹1,250.90
Mkt Cap₹13.27K Cr
P/E50.85
P/B6.58
ROE13.54%
52W High₹1,979.20
52W Low₹987.05
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
50.85
P/B Ratio
6.58
EV/EBITDA
31.54
Price/Sales
12.58
Dividend Yield (%)
0.60
EPS (TTM ₹)
24.94
Book Value (₹)
192.81
ROE (%)
13.54
ROCE (%)
18.04
ROA (%)
12.15
EBITDA Margin (%)
34.88
Net Profit Margin (%)
24.57
Debt/Equity
0.00
Current Ratio
7.39
Interest Coverage
419.57
Asset Turnover
0.49
Working Capital/Sales
0.98
Core EBITDA Growth (%)
-23.76
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 7129.33 | 85316.82 | 101693.92 | 120008.69 | 105489.07 |
| Net Sales | 7129.33 | 85316.82 | 101693.92 | 120008.69 | 105489.07 |
| Total Income | 7363.49 | 88847.75 | 105071.92 | 124453.36 | 110724.6 |
| Total Expenditure | 4390.08 | 50458.93 | 58475 | 69324.3 | 68695.06 |
| Operating Profit | 2973.41 | 38388.82 | 46596.92 | 55129.06 | 42029.54 |
| Depreciation | 500.5 | 5403.24 | 5359.15 | 5437.35 | 7445.86 |
| Exceptional Items | — | — | — | — | -327.54 |
| Profit Before Tax | 2375.18 | 32201.34 | 41256.5 | 49455.33 | 34464.72 |
| Tax | 625.89 | 8192.77 | 10446.18 | 12291.1 | 8541.81 |
| Profit After Tax (PAT) | 1749.29 | 24008.57 | 30810.32 | 37164.23 | 25922.91 |
| EPS (₹) | 16.72 | 22.95 | 29.45 | 35.52 | 24.78 |
| Dividend Payout % | 512 | 683 | 875 | 1070 | 755 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 95.11 | 1046.16 | 1046.16 | 1046.16 | 1046.16 |
| Reserves | 10937.12 | 127954.09 | 151618.39 | 180225.59 | 200659.97 |
| Shareholders Funds | 11032.23 | 129000.25 | 152664.55 | 181271.75 | 201706.13 |
| Total Debt | 605.86 | 3123.56 | 622.98 | 38.11 | 0 |
| Total Liabilities | 15018.69 | 151398.18 | 170070.85 | 203425.15 | 223179.05 |
| Total Assets | 15018.69 | 151398.18 | 170070.85 | 203425.15 | 223179.05 |
| Book Value / Share | 1159.9443 | 123.3083 | 145.9285 | 173.2734 | 192.8062 |
| Assets | 15018.69 | 151398.18 | 170070.85 | 203425.15 | 223179.05 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 2074.75 | 24600.18 | 26546.71 | 24451.69 | 26688.13 |
| Investing Activities | -1117.88 | -15795.01 | -15460.93 | -15998.65 | -14272.36 |
| Financing Activities | -1001.64 | -8521.94 | -9921.49 | -9876.8 | -11287.62 |
| Net Cash Flow | -44.77 | 283.23 | 1164.29 | -1423.76 | 1128.15 |
CONCORDBIO
₹1,250.90
-0.1%